Carbonyl reductases and pluripotent hydroxysteroid dehydrogenases of the shortchain dehydrogenase/reductase superfamily

被引:187
作者
Hoffmann, Frank [1 ]
Maser, Edmund [1 ]
机构
[1] Univ Kiel, Sch Med, Inst Toxicol & Pharmacol Nat Scientists, D-24105 Kiel, Germany
关键词
reductive drug metabolism; carbonyl reductase; hydroxysteroid dehydrogenase; pluripotency; aldo-keto reductase (AKR) superfamily; short-chain dehydrogenasereductase (SDR) superfamily;
D O I
10.1080/03602530600969440
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Carbonyl reduction of aldehydes, ketones, and quinones to their corresponding hydroxy derivatives plays an important role in the phase I metabolism of many endogenous (biogenic aldehydes, steroids, prostaglandins, reactive lipid peroxidation products) and xenobiotic (pharmacologic drugs, carcinogens, toxicants) compounds. Carbonyl-reducing enzymes are grouped into two large protein superfamilies: the aldo-keto reductases (AKR) and the short-chain dehydrogenaseslreductases (SDR). Whereas aldehyde reductase and aldose reductase are AKRs, several forms of carbonyl reductase belong to the SDRs. In addition, there exist a variety of pluripotent hydroxysteroid dehydrogenases (HSDs) of both superfamilies that specifically catalyze the oxidoreduction at different positions of the steroid nucleus and also catalyze, rather nonspecifically, the reductive metabolism of a great number of nonsteroidal carbonyl compounds. The present review summarizes recent-findings on carbonyl reductases and pluripotent HSDs of the SDR protein superfamily.
引用
收藏
页码:87 / 144
页数:58
相关论文
共 300 条
[1]   CLONING, SEQUENCING AND EXPRESSION OF PSEUDOMONAS-TESTOSTERONI GENE ENCODING 3-ALPHA-HYDROXYSTEROID DEHYDROGENASE [J].
ABALAIN, JH ;
DISTEFANO, S ;
ABALAINCOLLOC, ML ;
FLOCH, HH .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1995, 55 (02) :233-238
[2]   ON THE PHARMACOKINETICS OF TOBACCO-SPECIFIC N-NITROSAMINES IN FISCHER RATS [J].
ADAMS, JD ;
LAVOIE, EJ ;
HOFFMANN, D .
CARCINOGENESIS, 1985, 6 (04) :509-511
[3]   A STUDY OF TOBACCO CARCINOGENESIS .29. PHARMACOKINETICS OF N'-NITROSONORNICOTINE AND 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE IN LABORATORY-ANIMALS [J].
ADAMS, JD ;
LAVOIE, EJ ;
OMARAADAMS, KJ ;
HOFFMANN, D ;
CAREY, KD ;
MARSHALL, MV .
CANCER LETTERS, 1985, 28 (02) :195-201
[4]   EXPRESSION OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE USING RECOMBINANT VACCINIA VIRUS [J].
AGARWAL, AK ;
TUSIELUNA, MT ;
MONDER, C ;
WHITE, PC .
MOLECULAR ENDOCRINOLOGY, 1990, 4 (12) :1827-1832
[5]   DAUNORUBICIN REDUCTION MEDIATED BY ALDEHYDE AND KETONE REDUCTASES [J].
AHMED, NK ;
FELSTED, RL ;
BACHUR, NR .
XENOBIOTICA, 1981, 11 (02) :131-136
[6]   HETEROGENEITY OF ANTHRACYCLINE ANTIBIOTIC CARBONYL REDUCTASES IN MAMMALIAN LIVERS [J].
AHMED, NK ;
FELSTED, RL ;
BACHUR, NR .
BIOCHEMICAL PHARMACOLOGY, 1978, 27 (23) :2713-2719
[7]  
AHMED NK, 1979, J PHARMACOL EXP THER, V209, P12
[8]  
Ahrendt SA, 2000, CANCER RES, V60, P3155
[9]   Selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice [J].
Alberts, P ;
Engblom, L ;
Edling, N ;
Forsgren, M ;
Klingström, G ;
Larsson, C ;
Rönquist-Nii, Y ;
Öhman, B ;
Abrahmsén, L .
DIABETOLOGIA, 2002, 45 (11) :1528-1532
[10]   Identification of two closely related genes, inducible and noninducible carbonyl reductases in the rat ovary [J].
Aoki, H ;
Okada, T ;
Mizutani, T ;
Numata, Y ;
Minegishi, M ;
Miyamoto, K .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 230 (03) :518-523